Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety
Launched by ORYGEN · Mar 19, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Youth mental ill-health is a global crisis. One in five young people experience a mental health disorder every year, and suicide is a leading cause of death in this age group. In addition to costing the global economy $1 trillion per year in lost productivity, mental ill-health can have a severe and long-lasting impact on the lives of young people. Despite this, only a small proportion receive access to care, and of those that do, most fail to fully recover.
Technology has the potential to overcome many systemic barriers to accessing quality, sustainable care and importantly provide treatm...
Gender
ALL
Eligibility criteria
- There are three populations recruited for this trial:
- • INCLUSION CRITERIA
- • Young people
- • 1. Aged between 12-25 years (inclusive)
- • 2. Current client of a participating youth mental health service
- • 3. Seeking or receiving treatment for depression and/or anxiety
- • 4. Sufficient command of the English language
- • Clinicians Employed at a participating youth mental health service and involved in the delivery of psychological treatment of young people presenting with depression and anxiety
- • Service staff Work within a participating youth mental health service in a leadership (team lead or service manager) or administrative role.
- EXCLUSION CRITERIA:
- • Young people
- • 1. Moderate or severe audio or visual condition precluding engagement with the VR equipment (assessed on a case-by-case basis)
- • 2. Counter indication based on clinical judgement e.g., active suicidal risk or intellectual disability.
- • Clinicians Unable to commit to delivering the MIND intervention (5 sessions over 10-12 weeks).
- • Service staff Nil
Trial Officials
iMOGEN H Bell, PhD
Principal Investigator
Orygen
About Orygen
Orygen is a leading organization dedicated to advancing mental health care for young people through innovative research and clinical trials. Committed to improving the understanding and treatment of mental health disorders, Orygen leverages cutting-edge scientific approaches to develop evidence-based interventions. By collaborating with a diverse range of stakeholders, including academic institutions and healthcare providers, Orygen aims to translate research findings into practical solutions that enhance the well-being of youth. Their focus on early intervention and prevention positions them at the forefront of mental health innovation, striving to create a future where every young person has access to effective mental health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported